Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Neuberg Centre For Genomic Medicine, |
RCV000002568 | SCV004101553 | pathogenic | Adenylosuccinate lyase deficiency | criteria provided, single submitter | clinical testing | The missense variant c.1264G>T (p.Asp422Tyr) in ADSL gene has been reported in heterozygous state in individuals affected with Adenylosuccinase deficiency (Van Laer et al., 2018). Experimental studies have shown that this missense decrease in enzymatic activity of this mutant can be directly related to its reduced stability (Van Laer et al., 2018). This variant has allele frequency 0.001% in the gnomAD and novel in 1000 genome database. This variant has been reported to the ClinVar database as Uncertain significance. The amino acid Asp at position 422 is changed to a Tyr changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Asp422Tyr in ADSL is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. | |
OMIM | RCV000002568 | SCV000022726 | pathogenic | Adenylosuccinate lyase deficiency | 1998-02-27 | no assertion criteria provided | literature only |